Gene copy number profile of extracellular vesicles in body fluid to determine the sensitivity of ovarian cancer to the anticancer drug PARP inhibitors.
Evaluation equivalent to colonoscopy using serum markers is possible.
Diagnostic biomarkers for stratification of COVID-19 patients and prediction of prognostic severity.
Expression of Largen gene predicts malignancy
Biomarkers for prediction and diagnosis of interstitial pneumonia, a side effect of cancer treatment with immune checkpoint inhibitors
NDE isolation by APLP1 is a powerful CNS research platform technology
POI could be diagnosed by detecting autoantibody reacting to POTE proteins expressing in ovarian tissue
Screening test for early stage gastric cancer, esophageal cancer and colorectal cancer patients by measuring urine miRNAs specific to each cancer.